A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Giambi, Cristina ^a,b   Bella, Antonino ^a   Barale, Antonella ^c   Montù, Domenico ^d   Marchisio, Maria ^e   Oddone, Maurizio ^e   Zito, Salvatore ^d   Rapicetta, Maria ^a   Chionne, Paola ^a   Madonna, Elisabetta ^a   Ciofi degli Atti, Marta L ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Regional Unit of Infectious Disease Epidemiology   (Italy)

^d Local Health Unit 17   (Italy)

^e Local Health Unit 19 Asti   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; ENGERIX B 10; HBVAXPRO 5; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; INFANTRIX HEXA; POLIOMYELITIS VACCINE; HEPATITIS B ANTIBODY; VACCINE;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERSISTENT INFECTION; POLIOMYELITIS; PRESCHOOL CHILD; BLOOD; COMPARATIVE STUDY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ITALY; PROSPECTIVE STUDY;

CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; ITALY; MALE; PROSPECTIVE STUDIES; VACCINES, COMBINED;

EID: 51249123074     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-100     Document Type: Article

References (20)

1. Mast E Mahoney F Kane M Margolis H Hepatitis B Vaccine Vaccines USA, Saunders Plotkin SA, Orenstein WA 2004:299-337
2. Van Herck K Van Damme P Thoelen S Meheus A Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results Vaccine 1998, 16(20):1933-35 10.1016/ S0264-410X(98)00126-1 9796046
3. Ayerbe MC Pérez-Rivilla et ICOVAHB group Assessment of long-term efficacy of hepatitis B vaccine Eur J Epidemiol 2001, 17:151-56 10.1023/ A:1017922302854
4. Watson B West DJ Chilkatowsky A Piercy S Ioli VA Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine Vaccine 2001, 19:3164-68 10.1016/S0264-410X(01)00019-6 11312012
5. Seto D West DJ Ioli VA Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth Pediatr Infect Dis J 2002, 21:793-95 10.1097/00006454-200208000-00021 12233715
6. Williams LT Goldstein ST Tufa J Tauillii S Margolis HS Mahoney FJ Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination Pediatr Infect Dis J 2003, 22:157-63 10.1097/00006454-200302000-00013 12586980
7. Floreani A Baldo V Cristofoletti M Renzulli G Valeri A Zanetti C Trivello R Long-term persistence of anti-HBs after vaccination against HBV: An 18 year experience in health care workers Vaccine 2004, 22:607-10 10.1016/j.vaccine.2003.09.001 14741151
8. Saffar MJ Rezai MS Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth Indian Pediatric 2004, 41:1232-37 15623904
9. Dentinger CM McMahon BJ Butler JC Dunaway CE Zanis CL Bulkow LR Bruden DL Nainan OV Khristova ML Hennessy TW Parkinson AJ Persistence of antibody to hepatitis B and protection from disease among Alaska Natives immunized at birth Pediatr Infect Dis J 2005, 24:786-92 10.1097/ 01.inf.0000176617.63457.9f 16148845
10. Duval B Gilca V Boulianne N Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country Pediatr Infect Dis J 2005, 24:213-18 10.1097/01.inf.0000154329.00361.39 15750456
11. McMahon BJ Bruden DL Petersen KM Bulkow LR Parkinson AJ Nainan O Khristova M Zanis C Peters H Margolis HS Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up Annal Intern Med 2005, 142(5):333-41 15738452
12. Zanetti AR Mariano A Romanò L D'Amelio R Chironna M Coppola RC Cuccia M Mangione R Marrone F Negrone FS Parlato A Zamparo E Zotti C Stroffolini T Mele A Study Group Long-term immunogenicity of hepatitis B vaccination and policy for booster: An Italian multicentre study Lancet 2005, 366:1379-84 10.1016/S0140-6736(05)67568-X 16226616
13. FitzSimons D Francois G Hall A McMahon B Meheus A Zanetti A Duval B Jilg W Böcher WO Lu SN Akarca U Lavanchy D Goldstein S Banatvala J Damme PV Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants Vaccine 2005, 23:4158-66 10.1016/ j.vaccine.2005.03.017 15964484
14. European Consensus Group on Hepatitis B Immunity Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000, 355(9203):561-5 10.1016/S0140-6736(99)07239-6 10683019
15. World Health Organization Hepatitis B Vaccine Core information for the development of immunization policy. Document WHO/V&B/02.28, 2002 Geneva, WHO 2002
16. Press Release. European Medicines Agency recommends suspension of Hexavac http://www.emea.europa.eu/humandocs/PDFs/EPAR/Hexavac/ 29736905en.pdf Last access: 08 August 2008
17. Hammitt LL Hennessy TW Fiore AE Zanis C Hummel KB Dunaway E Bulkow L McMahon BJ Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years Vaccine 2007, 25:6958-64 10.1016/j.vaccine.2007.06.059 17714836
18. Yuen MF Lim WL Cheng CC Lam Sk Lai CL Twelve-year follow up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children Hepatology 1999, 29:924-27 10.1002/hep.510290327 10051499
19. Petersen KM Bulkow LR McMahon BJ Zanis C Getty M Peters H Parkinson AJ Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth Pediatr Infect Dis J 2004, 23:650-55 10.1097/01.inf.0000130952.96259.fd 15247604
20. Samandari T Fiore AE Negus S Williams JL Kuhnert W McMahon BJ Bell BP Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescent vaccinated during infancy Pediatrics 2007, 120(2):e373-81 10.1542/peds.2007-0131 17636112